Cigna Stock News

BLOOMFIELD, Conn. , Feb. 28, 2022 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE: CI ) today announced a series of capital deployment priorities designed to enhance shareholder value and deliver long-term growth. Cigna expects to generate over $12 billion of deployable capital in 2022, including $5.4 billion in after-tax proceeds from the previously announced sale of its international life, accident, and supplemental benefits businesses in seven countries. These priorities build on the capital Cigna returned to shareholders in 2021, including $7.7 billion of share repurchase and $1.3 billion in dividends. During Cigna''s February Board of Directors meetings, directors approved an aggregate increase of $6 billion in incremental share repurchase authorization, bringing the company''s total share repurchase authority to $10 billion . Year-to-date, Cigna has repurchased $1.2 billion of its shares. The company expects to deploy in excess of $7 billion for share repurchase this year with Cigna''s equity trading at an attractive and compelling valuation, as the company is not currently contemplating large-scale mergers or acquisitions. "Our plans for significant share repurchase coupled with our recently increased dividend, reinforces the confidence we have in our long-term growth plans and the underlying earnings power of Cigna''s business portfolio.

Health care company Cigna Corp. CI, +3.75% said Monday its board has approved a series of capital deployment moves for 2022, including new share buybacks and strategic investments. The board has appro

Executive Overview 53 Liquidity and Capital Resources 59 Critical Accounting Estimates 63 Segment Reporting 67 Evernorth 67 Cigna Healthcar e 69 Other Operations 71 Corporate 72 Investment Assets 72 Management''s Discussion and Analysis of Financial Condition and Results of Operations is intended to provide information to assist you in better… The post CIGNA CORP – 10-K – MANAGEMENT''S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS PAGE appeared first on InsuranceNewsNet .

Income investments are great for volatile times, as investors dump technology stocks and seek steady dividends and capital gains. The post 7 High-Yield Blue-Chip Stocks Suitable for Any Retiree appear

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

BMO chooses Broadcom, Pfizer, Cigna, Fortune Brands, Ross Stores, Parker-Hannifin, CSX and International Paper.

Cigna has participated in the rotation from growth to value, but still trades at 10x earnings. The company has been an aggressive buyer of its own stock.

Cigna <> was downgraded by RBC Capital to Sector Perform from Outperform with a price target of $235, down from $304.RBC Capital analyst Ben Hendrix said the company''s Q4 earnings

Monday''s top analyst upgrades and downgrades included Bill.com, Cigna, ConocoPhillips, Estee Lauder, Fortinet, Microchip Technology, Pfizer, Skyworks Solutions, Snap, Snowflake, VICI Properties and Wipro.

Neuberger Berman Group LLC raised its holdings in Cigna Co. by 7.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The

Cigna is a well-run, vertically integrated health insurance provider that's seeing top and bottom line growth.

Deutsche Bank analyst George Hill has downgraded the Cigna <> to Hold from Buy, arguing that the health insurer lacks a catalyst to expand its multiple